Clin2
NCT07218354Possibly a fitRecruiting

Medication for reducing alcohol use in veterans

Alcohol Use Disorder

Treatments studied

Part of Mental health clinical trials.

This study tests whether a medication (semaglutide) can help veterans reduce or stop drinking alcohol. It is for veterans who drink heavily and have alcohol use disorder, and who are interested in cutting down.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
622 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • Must be a veteran.
  • Must have high or very high risk drinking level in the past 28 days.
  • Must have a diagnosis of moderate or severe alcohol use disorder.
  • Must be willing to reduce alcohol consumption.
  • Must not have certain medical conditions (e.g., type 1 diabetes, pancreatitis, advanced liver disease) or be taking certain medications (e.g., diabetes or alcohol use disorder medications).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06546384Not yet recruiting
Semaglutide for alcohol use and liver health in obesity and fatty liver

This study tests if semaglutide (a GLP-1 RA medicine) can reduce alcohol consumption and improve liver fat and metabolism in people with obesity and fatty liver disease who drink above certain levels.

Bern
NCT07223983Recruiting· Phase 1
Semaglutide for alcohol use disorder after weight loss surgery

This trial tests if a once-weekly diabetes medication (semaglutide) can help people with alcohol use disorder who have had gastric bypass or sleeve gastrectomy in the past 7 years. It may reduce alcohol cravings or drinking.

New Haven, Connecticut
NCT07249554Not yet recruiting· Phase 2
Combination therapy for alcohol use disorder

This trial tests two medicines — semaglutide and naltrexone — taken together to help reduce alcohol cravings and drinking. It aims to see if this combination is more effective than standard treatment for alcohol use disorder.

Havre de Grace, Maryland
NCT07040592Recruiting· Phase 2
Semaglutide for HIV and alcohol use

This study is testing whether semaglutide, a medication already used for diabetes and weight loss, can help people with HIV who also have an alcohol use disorder cut back on drinking. It is for patients treated at the Atlanta VA Healthcare System.

Decatur, Georgia
NCT07772960Not yet recruiting· Phase 1
Semaglutide for alcohol use and weight loss

This study tests whether semaglutide, a medication that helps with weight loss, can also reduce alcohol cravings and drinking in people with alcohol use disorder. It may help you drink less and lose weight.

New Haven, Connecticut
NCT07221214Recruiting· Phase 2
Testing a diabetes drug for drinking and heart health in HIV

This trial tests if a once-weekly diabetes medication (semaglutide) can help people with HIV reduce heavy drinking and improve heart health. It's for people who drink alcohol and have a higher body weight.

Nashville, Tennessee

Hear when a new Alcohol Use Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.